NewsRx

Search our medical news database

SAS

SAS® Powers Small, Midsize Biotech and Pharmaceutical Companies

Published in Vaccine Weekly, April 1st, 2009

Despite the recession, pharmaceutical and biotech companies continue to invest in discovery and development of advanced, life-saving therapies. Small and midsize life science firms leading the quest to deliver innovative products use SAS analytics to speed drug development and facilitate regulatory compliance.

“Drug discovery and clinical trials entail years of work and millions of start-up dollars,” said Jason Burke, Worldwide Director of Health and Life Sciences at SAS. “For small and midsize firms with limited capital and staffing, ease of regulatory compliance, analysis and insight is paramount. And new drugs from these startup firms are driving growth at many top...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook